XML 33 R23.htm IDEA: XBRL DOCUMENT
v3.22.1

Stock-Based Compensation | 3 Months Ended
--- | ---
Mar. 31, 2022
Stock-Based Compensation |
Stock-Based Compensation | Note 14. Stock-Based Compensation Stock Options We have five stock incentive plans: the 2002 Stock Incentive Plan (the “2002 Plan”), the 2009 Stock Incentive Plan (the “2009 Plan”), the 2011 Stock Incentive Plan (the “2011 Plan”), the 2015 Omnibus Equity Incentive Plan (the “2015 Plan”), and the 2018 Omnibus Equity Incentive Plan (the “2018 Plan”), (collectively, the “Plans”). The 2002 Plan, the 2009 Plan, the 2011 Plan and the 2015 Plan (the “Prior Plans”) have been superseded by the 2018 Plan. In May 2018, the stockholders approved the 2018 Plan for issuances up to an aggregate of 3,730,179 shares plus 1,269,821 shares that were authorized but unissued under the Prior Plans as of the effective date of the 2018 Plan and in April 2021, the stockholders approved an increase of 2,850,000 shares authorized under the 2018 Plan. The Prior Plans will remain in effect until all awards granted under such Prior Plans have been exercised, forfeited, cancelled, or have otherwise expired or terminated in accordance with the terms of such awards, but no awards will be made pursuant to the Prior Plans after the effectiveness of the 2018 Plan. As of March 31, 2022, the Company had 6,217,288 shares available for future awards under the 2018 Plan. During the three months ended March 31, 2022 and 2021, we granted stock options at exercise prices equal to the quoted market price of our common stock on the grant date. The fair value of each option grant was estimated on the date of grant using Black-Scholes with the following weighted average assumptions: ​
​ | ​ | ​ | ​ | ​
​ | ​ | March 31,
​ |  | 2022 |  | 2021
Expected life (years) | ​ | 4.2 - 5.2 | ​ | 3.5 - 6.1
Risk-free interest rate |  | 2.1% - 2.3 | % | 0.5% - 0.9%
Volatility | ​ | 72.8% - 76.8 | % | 64.4% - 80.8%
Dividend yield |  | 0% | ​ | 0%
​ The expected option life assumption is estimated based on the simplified method. Accordingly, the Company has utilized the average of the contractual term of the options and the weighted average vesting period for all options to calculate the expected option term. The risk-free interest rate assumption is based upon observed interest rates appropriate for the expected term of our employee stock options. The expected volatility is based on the average of the historical volatility and the implied volatility of our stock commensurate with the expected life of the stock-based award. We do not anticipate paying dividends on the common stock in the foreseeable future. We recognize stock-based compensation cost on a straight-line basis over the vesting period. Stock-based compensation expense is recognized only for those awards that ultimately vest. Total stock-based compensation expense related to all of our share-based payment awards is comprised of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31,
​ |  | 2022 |  | 2021
Cost of revenues | ​ | $ | 467 | ​ | $ | 239
Selling, general and administrative | ​ |  | 3,291 | ​ |  | 2,505
Engineering and development | ​ |  | 367 | ​ |  | 246
​ | ​ | $ | 4,125 | ​ | $ | 2,990
​ A summary of stock option activity is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted- | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted- | ​ | Average | ​ | ​ | ​
​ | ​ | ​ | ​ | Average | ​ | Remaining | ​ | Aggregate
​ | ​ | Number of | ​ | Exercise | ​ | Contractual | ​ | Intrinsic
​ |  | Shares |  | Price/Share |  | Term (Years) |  | Value (1)
Outstanding — December 31, 2021 |  | 7,027,941 | ​ | $ | 13.97 |  |  |  | ​ |
Granted (weighted-average fair value of $18.45 per share) | ​ | 429,467 | ​ | ​ | 32.18 | ​ |  | ​ | ​ | ​
Exercised |  | (85,058) |  | ​ | 4.71 |  |  |  | ​ | ​
Forfeited |  | (7,550) |  | ​ | 54.26 |  |  |  | ​ | ​
Outstanding — March 31, 2022 |  | 7,364,800 | ​ | $ | 15.09 |  | 5.7 | ​ | $ | 158,839
Vested (exercisable) — March 31, 2022 |  | 5,624,632 | ​ | $ | 9.99 |  | 5.2 | ​ | $ | 143,609
Expected to vest after March 31, 2022 (unexercisable) |  | 1,740,168 | ​ | $ | 31.59 |  | 7.4 | ​ | $ | 15,229
(1) | Aggregate intrinsic value represents the difference between the exercise price of the option and the closing market price of our common stock on March 31, 2022, which was $34.91 per share.
Total intrinsic value of options exercised during the three months ended March 31, 2022 and 2021 was $2.9 million and $9.4 million, respectively. As of March 31, 2022, there was unrecognized compensation expense of $31.9 million related to unvested stock options, which we expect to recognize over a weighted average period of 2.8 years. Restricted stock units A summary of our restricted stock unit activity is as follows:
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted Average
​ | ​ | Number of Restricted | ​ | Fair Value per
​ | ​ | Stock Units | ​ | Share
Outstanding – December 31, 2021 |  | 373,849 |  | $ | 55.53
Granted |  | 391,327 | ​ |  | 32.15
Share issuance | ​ | (58,395) | ​ | ​ | 53.98
Forfeited |  | (12,894) | ​ |  | 57.03
Outstanding – March 31, 2022 |  | 693,887 | ​ | $ | 42.45
​ For the three months ended March 31, 2022 and 2021, we recorded stock-based compensation expense on our issued restricted stock units of $1.4 million and $0.3 million, respectively. As of March 31, 2022 there was unrecognized compensation expense of $27.0 million related to unvested restricted stock units, which we expect to recognize over a weighted average period of 3.5 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration